The Patent Finder

Terms ending in 2030

Musc Foundation for Research Development

Every in-force patent on Musc Foundation for Research Development's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,911,958Methods for Assessing Modified LDL Immune Complexes in Subjects Having or at Risk of Coronary Artery Disease
In force
 · Medium confidence
Department of Veterans AffairsIn forceMedium confidence
US 9,260,517Human Monoclonal Antibodies to Human Nucleolin
In force
 · High confidence
Musc Foundation for Research DevelopmentIn forceHigh confidence
US 10,385,128Nucleolin Antibodies
In force
 · High confidence
Musc Foundation for Research DevelopmentIn forceHigh confidence
US 8,409,603Compositions and Methods for Tissue Engineering, Tissue Regeneration and Wound Healing
In force
 · High confidence
Musc Foundation for Research DevelopmentIn forceHigh confidence
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited